Prostate Cancer
Which patients are at the highest risk of dying from competing causes ≤10 years after radical prostatectomy? - Abstract
November 22, 2011
Role of lymphadenectomy for prostate cancer: Indications and controversies - Abstract
November 22, 2011
Personalized approach to prostate cancer prognosis - Abstract
November 22, 2011
Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy - Abstract
November 21, 2011
The role of sipuleucel-T in therapy for castration-resistant prostate cancer: A critical analysis of the literature - Abstract
November 21, 2011
High-risk prostate cancer: Value of multi-modality 3T MRI-guided biopsies after previous negative biopsies - Abstract
November 21, 2011
Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead - Abstract
November 21, 2011
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC) - Abstract
November 18, 2011
Focal cryotherapy for localized prostate cancer: A report from the national Cryo On-Line Database (COLD) Registry - Abstract
November 18, 2011
Prostate-cancer screening - what the U.S. Preventive Services Task Force left out - Abstract
November 18, 2011
One man at a time - resolving the PSA controversy - Abstract
November 18, 2011
Defining and predicting indolent and low risk prostate cancer - Abstract
November 18, 2011
Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy - Abstract
November 18, 2011
Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: Treating to doses beyond 78 Gy - Abstract
November 18, 2011
Robot-assisted versus open radical prostatectomy: An evidence-based comparison - Abstract
November 17, 2011